Corporate Accountability

CAC Alert: Oral Arguments in Nestlé USA, Inc. v. John Doe I and Cargill, Inc. v. John Doe I

CAC Appellate Counsel Dayna Zolle discusses oral arguments in the #SCOTUS case that could determine whether suits against U.S. corporations under the Alien Tort Statute must be dismissed simply because the defendants are corporations.

More from Corporate Accountability

Corporate Accountability
April 24, 2026

CAC Release: Supreme Court Considers Constitutionality of FCC Enforcement Process

WASHINGTON, DC – Following oral argument at the Supreme Court this morning in Federal Communications...
By: Joshua Blecher-Cohen, Smita Ghosh
Corporate Accountability
U.S. Supreme Court

Federal Communications Commission v. AT&T and Verizon v. Federal Communications Commission

In Federal Communications Commission v. AT&T and Verizon v. Federal Communications Commission, the Supreme Court is considering whether the FCC’s two-stage civil-enforcement process violates the Seventh Amendment.
Corporate Accountability
January 15, 2026

January Newsletter: CAC Keeps Up the Fight for Corporate Accountability

Corporate Accountability
U.S. Court of Appeals for the Sixth Circuit

Millennia Housing Management v. Department of Housing and Urban Development

In Millennia Housing Management v. Department of Housing and Urban Development, the United States Court of Appeals for the Sixth Circuit is considering a challenge to the Department of Housing and Urban Development’s authority to...
Corporate Accountability
July 2, 2025

Moneyed Interests Still Prevail at the Supreme Court (2024-2025 Term)

The Court Continues to Favor Corporations over Workers, Consumers, and the Environment.
By: Brian R. Frazelle, Ana Builes
Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...